Concepedia

Rumi Kawamura

RK

Statistics

Publications

5

Citations

562

H-Index

5

Active since

2012

Affiliations

California Pacific Medical Center(Current)

Rumi Kawamura is an author at California Pacific Medical Center specializing in medicine, oncology, and molecular oncology.

Publications per year

2012–2017

5

Publications

5

Cannabidiol inhibits paclitaxel‐induced neuropathic pain through 5‐<scp>HT<sub>1A</sub></scp> receptors without diminishing nervous system function or chemotherapy efficacy

Sara Jane Ward, Sean D. McAllister, Rumi Kawamura et al. · British Journal of Pharmacology · 2013 · 277 citations · Full text

Medicine, Oncology, Pharmacology +17

Id-1 Is a Key Transcriptional Regulator of Glioblastoma Aggressiveness and a Novel Therapeutic Target

Liliana Soroceanu, Ryuichi Murase, Chandani Limbad et al. · Cancer Research · 2012 · 154 citations · Full text

Medicine, Cell Biology, Oncology +17

Targeting multiple cannabinoid anti‐tumour pathways with a resorcinol derivative leads to inhibition of advanced stages of breast cancer

Ryuichi Murase, Rumi Kawamura, Eric A. Singer et al. · British Journal of Pharmacology · 2014 · 83 citations · Full text

Medicine, Oncology, Pharmacology +14

Distinct Benefit of Overall Survival between Patients with Non-Small-Cell Lung Cancer Harboring <b><i>EGFR</i></b> Exon 19 Deletion and Exon 21 L858R Substitution

Nobuyuki Koyama, Yasutaka Watanabe, Yuki Iwai et al. · Chemotherapy · 2017 · 25 citations

Medicine, Oncology, Pharmacology +15

Suppression of invasion and metastasis in aggressive salivary cancer cells through targeted inhibition of ID1 gene expression

Ryuichi Murase, Tomoki Sumida, Rumi Kawamura et al. · Cancer Letters · 2016 · 23 citations

Medicine, Cancer Biology, Oncology +10

1–5 of 5